Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 4Recruiting 4Withdrawn 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Lung Neoplasms 1Carcinoma, Transitional Cell 1Advanced Solid Tumors 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Biomarkers × Clear all
NCT04770974 2022-05-09

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

University of Florence

Unknown
200 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03286036 2019-02-15

Clinical and Molecular Staging of Lung Cancer Stages I and IIp

Corporacion Parc Tauli

Unknown
200 enrolled
Thoracic

Lung Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01867073 2013-06-03

A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

National University Hospital, Singapore

Unknown
20 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡